Promote Sponsor
verified SJR 7,884 · Q1 • database Scopus / SJR & Web of Science indexed
Nature Reviews Endocrinology
United Kingdom · Nature Publishing Group
workspace_premium Q1 — Endocrinology lock Subscription Unclaimed

Nature Reviews Endocrinology

Nature Reviews Endocrinology is a journal indexed in SJR in Endocrinology and Endocrinology, Diabetes and Metabolism with an H index of 224. It has an SJR impact factor of 7,884 and it has a best quartile of Q1. It has an SJR impact factor of 7,884.

Nature Reviews Endocrinology focuses its scope in these topics and keywords: insulin, gut, lipid, marrow, metabolic, health, glucose, exercise, diabetes, d, ...

ISSN: 1759-5029
Editorial: Nature Publishing Group
Category: Endocrinology
Indexation: verifiedScopus / SJR verifiedWeb of Science

Unclaimed profile — some fields may be incomplete.

open_in_new Portal NPD menu_book Guidelines NPD
schedule Datos CoP · solo campos en BD
SJR Impact Factor trending_up
7,884 Q1
H-index 224
Tasa de Aceptación pie_chart
21% Selectiva
Fuente Acceptance_Rate
Tiempo a publicación hourglass_top
NPD
Campo Sin dato
Coste de Publicación (APC) payments
NPD Subscription
Ruta Non-OA NPD

Metrics

Campos Scimago / CoP — sin series inventadas

Scopus / SJR Web of Science

SJR Impact

7,884

H-index

224

Docs (year)

130

Docs 3y

472

Total refs

8275

Cites 3y

5931

Citable 3y

231

Cites/Doc 2y

11.82

Ref/Doc

63.65

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

—

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims
rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.
User
* Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Antithyroid drug-induced fetal goitrous hypothyroidism

View more

Zoledronic acid and teriparatide: better together?

View more

Diabetes, puberty and PCOS risk

View more

Correction: Statin therapy for skeletal dysplasia

View more

Cholesterol metabolites regulate motor neuron function

View more

Can inflammatory status define metabolic health?

View more

Brain, mind, insulin - what is normal and do we need to know?

View more

Brain changes in T1DM - a microvascular complication?

View more

Blood pressure reduction in diabetes: lessons from ACCORD, SPRINT and EMPA-REG OUTCOME

View more

beta cells at last

View more

Benefits of intensive lifestyle modification programs in the spotlight

View more

Balancing BMI - rethinking the relationships between obesity, ageing and risk of dementia

View more
SHOW MORE ARTICLES

Back to the origins - identifying the skeletal stem cell

View more

A conundrum addressed: the prognostic value of HbA1c

View more

Antihelminthic drug for T2DM therapy?

View more

Anti-Mullerian hormone: an ovarian reserve marker in primary ovarian insufficiency

View more

Amputation rates fall in Finland

View more

Advances in therapy of adenomas secreting GH, ACTH and TSH

View more

Adenosine activates human and murine brown adipose tissue

View more

Addisonian crisis in a young man with atypical anorexia nervosa

View more

Acinar-cell reprogramming generates functional beta cells that persist for a long time

View more

A role for CFTR in beta-cell function

View more

A patient with diabetes insipidus, anterior hypopituitarism and pituitary stalk thickening

View more

A patient with a large recurrent pheochromocytoma demonstrating the pitfalls of diagnosis

View more

FAQS